Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Insider Window

<< Previous

Bullboard Posts

Next >>

Comment by PinnacleXon Oct 17, 2022 4:30pm

75 Views

Post# 35029958

RE:Insider Window

Wino115 wrote: Let's hope our friends with the options did not exercise and sell into this nice strength today, bringing it all the way back home. I would love to see management and Board increasing exposures since this may be the last window before February that they can do something. Realistically, I don't expect any buying, but I hope not to see any selling either.

Nice strenght lol. Where is SPECO? hes the death blow when he speaks this tanks.

<< Previous

Bullboard Posts

Next >>

Mid-year update: Charting GameSquare’s sharp business growth